Summary:
The TOMMORROW study seeks to learn more about the genetic risk for developing mild cognitive impairment due to Alzheimer’s disease (MCI due to AD) and whether an investigational medication might prove effective in delaying the early symptoms of this condition. The research study is currently recruiting healthy senior participants. Find out more about being part of this important research effort.
Qualified Participants Must:
• Be Between 65 and 83 years of age
•
Be in general good health overall
•
Not be taking insulin
•
Have a project partner for a limited number of the study visits
Qualified Participants May Receive:
Study medication, procedures at no cost, and
compensation for time and travel.